Warpaint London – Bullish H1 Trading Update Is Due This Week From Specialist Colour Cosmetics Supplier

Suggesting that Warpaint London (LON:W7L) is a great success story of British enterprise, analysts Darren Shirley and Clive Black at Shore Capital recently upgraded their current year forecasts by some 26% to look for adjusted pre-tax growth to £23.3m, generating 22.6p of earnings per share.

Warpaint sells branded cosmetics, its W7 brand is sold in the UK primarily to major retailers and internationally to local distributors or retail chains.

While Technic, the group’s other main brand, is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets.

Looking For Strong Multi-Year Growth

The brokers suggest that Warpaint is in the foothills for growth, such foothills have a considerable distance to traverse, and they believe that strong multi-year growth beckons.

Their estimates for the year to end December 2025 are for £116.5m sales, adjusted pre-tax profits of £26.6m, with earnings of 25.8p and a 12.9p dividend per share.

Buy On Any Dips

In late April I wrote that patient investors in Warpaint should look to buy on any dips in the price, and that by doing so they will be onto a winner.

The shares were then 465p and fell back to 455p after news that the group’s CEO and Managing Director were sellers of 3.5m shares a piece, some 9.06% of the equity, ‘in response to strong investor demand’ and wanting to increase the freefloat of its stock and broadening the shareholder register.

Following the Placing at 450p a share, Samuel Bazini, CEO, and Eoin Macleod, MD, were each left with 15.95m shares, representing 20.64% each of the equity.

Share Price Strength Subsequent To Placing

That Placing was substantially oversubscribed and was strongly supported by existing and many new institutional investors.

The group’s shares have been on a gradual ascent since then, topping out at 550p late last week – showing a near-21% gain since the Placing.

The company is due to announce its H1 Trading Update this week.

Chemring Group announces Norwegian missile deal

On Monday, Chemring Group announced a significant long-term agreement between its Norwegian subsidiary, Chemring Nobel, and American aerospace and defense giant Northrop Grumman.

The 15-year partnering deal secures Chemring Nobel as a supplier of HMX, a powerful energetic material used in missile propellants, to Northrop Grumman’s missile programs.

Alongside the 15-year partnership, Northrop Grumman has also placed an $83 million delivery order with Chemring Nobel for HMX supplies. Deliveries under this order will commence in fiscal year 2026 and continue over the following three years. All production will take place at Chemring Nobel’s facility located in Sӕtre, Norway.

“These awards, which illustrate the long-term and valued relationship that we enjoy with Northrop Grumman, support our decision to invest in increasing the capacity of our three energetics businesses over the medium-term, and reinforces Chemring’s position as a key supplier to NATO,” said Michael Ord, Chief Executive of Chemring.

Adriatic Metals – $50m Institutional Placing To Speed Into Silver Production, With Analysts Looking For 50% Share Price Uplift

Just four weeks ago the shares of Adriatic Metals (LON:ADT1) were trading at 253p, by the middle of last week they had fallen back to 196p, before closing on Friday night at a slightly improved 203p.

From this level, market analysts are said to be looking for a recovery back to and then above the 253.50p at which they peaked on 21st May.

The £658m-capitalised Cheltenham-based precious and base metals mining group is the owner of the Vares Silver Operation, which covers a 44sq.km area in Bosnia and Herzegovinia.

It also owns the Raska Zinc-Silver Project in Serbia.

Vares Silver Operation

The world-class Vares site is gaining most investor attention, it contains two advanced exploration deposits, Veovaca and Rupice, which have previously been mined for Lead, Zinc and Barite.   

The company’s exploration programme is focused on the northern and southern extremities of Rupice. 

At the end of May, the company announced that it had agreed a sale of on-specification grade concentrates from Vares.

Currently, it produces high-quality concentrates, with silver content exceeding 2,500g/t and nearly 50% zinc.

It dispatched the first shipment of ore concentrate from the Vares processing plant to the port of Ploče, officially initiating the first sales contract for the concentrate and securing the first million-dollar payment from international buyers.

The company has rapidly achieved significant success with the first shipment of concentrate from the Vareš mine, less than three months after starting production.

Noteworthy too was that it has also reconstructed the railway line connecting Vares with the port of Ploče, enabling ore transport to smelters in Belgium, Norway, Sweden, Spain, and Italy.

With increasing feed tonnage of development ore available, the processing plant will now transition to 24-hour operations in anticipation of first stopes in July.

The company is continuing to ramp up production, with nameplate capacity expected in the final quarter of this year.

CEO Paul Cronin stated that:

“The production of saleable concentrates from the Vares Silver Operation represents a major milestone for the Company and I am very pleased with the progress made by the processing team with the plant producing concentrates with recoveries as expected.

High silver, gold and zinc prices and low treatment charges due to a tight concentrate market are providing positive tailwinds for Adriatic’s free cash flow generation, as we progress towards full production capacity in Q4 of this year.”

Recent $50m Placing

At the same time in late May, Adriatic announced a $50m institutional placement of stock, with the fresh funds expected to boost the company’s balance sheet as it continues to progress the ramp-up and building upon of recent milestones, such as the production of the first saleable concentrate, and then further towards delivering on its mine plan.

Market analysts have Price Objectives of around 300p on the group’s shares.

Directors deals: Gooch & Housego on course for recovery

Gooch & Housego (LON: GHH) chairman Gary Bullard has bought 3,000 shares in the photonics company at 550p each following the interim figures. Earlier in the year, he made three purchases totalling 5,140 shares and all were acquired at 494p/share.
The previous purchases were done when the share price was falling due to a disappointing AGM trading statement and chief executive Charlie Peppiatt also bought 2,000 shares at 490p each at the same time. The latest purchase takes Gary Bullard’s stake to 46,700 shares.
Business
Destocking hit the interim figures of Gooch & Housego and pre-tax p...

Aquis weekly movers: Incanthera orders doubled

Skincare treatments developer Incanthera (LON: INC) says the first production order for its Skin + CELL products from Marionnaud has been doubled to 100,000 units. The launch will be in September. The previous figure was already higher than the initial order and the revenues from the order will be £4m. Future production orders could be even larger. This will help group revenues for the year to March 2025 to be more than £10m. This has enabled Incanthera to raise £4.1m from a share issue at 15p/share to cover additional working capital. The share price jumped 21.1% to 23p. Lupus treatment developer ImmuPharma (LON: IMM) raised £1.5m from the sale of its 9.98% stake in Incanthera, which was valued at £600,000 at the end of 2023, although it retains warrants.

TruSpine Technologies (LON: TSP) is talking to several potential commercial partners for its medical device technology, where the regulatory process is ongoing. The new board has improved relations with the inventor of the spinal stabilisation device IP. The investor relations website has been relaunched and a new medical advisory board will be put in place. The share price improved 14% to 3.25p.  

Bitcoin mining company Vinanz Ltd (LON: BTC) has received the first 20 bitcoin mining machines for its central Iowa facility. The share price edged up 0.98% to 12.875p.

FALLERS

Rogue Baron (LON: SHNJ) consolidated six existing shares into one new share following its AGM. The share price of the spirits brands owner fell 38.5% to 1.2p.

CBD products supplier Voyager Life (LON: VOY) says another potential merger has fallen through. This follows the ending of the Northern Leaf deal. This has left Voyager Life short of cash. The business operations are being reviewed and there are talks about funding. The company has been winning new business and there are signs of an improvement in the retail stores. The share price slumped 35.3% to 2.75p.

Psych Capital has changed its name to Shortwave Life Sciences (LON: PSY). The share price dipped 8% to 2.3p.

Invinity Energy Systems (LON: IES) has leased an additional manufacturing facility in Motherwell. This should become operational in the third quarter and capacity should be more than 500MWh of energy storage per year. The Bathgate facility will also be upgraded. The share price slid 4.44% to 21.5p.

KR1 (LON: KR1) has invested $1m into the Avail Web3 infrastructure project in return for 12.5 million AVAIL tokens. The share price decreased 1.9% to 77.5p.

Arbuthnot Banking Group (LON: ARBB) has completed the renewal of its subordinated loan, which is classified as Tier 2 capital. The loan was increased by £1m to £26m and lasts until June 2034. The share price declined 1.29% to 960p.

Tip update: Early land disposal for Hargreaves Services

Excavation and support services provider Hargreaves Services (LON: HSP) has done slightly better than expected in the year to May 2024 and that has led to a profit forecast upgrade. Although, the 2024-25 figure has been trimmed. The dividend will be 36.6p/share.
Hargreaves Land completed a deal slightly earlier than anticipated, which led to the gain moving into 2023-24. Net cash was better than expected at £22.7m at the end of May 2024 because of the property deal completion.
Singer forecasts pre-tax profit of £16.6m, but the 2024-25 forecast is reduced by the same amount as the additional co...

AIM weekly movers: Tasty restructuring

0

There was no news from Eurasia Mining (LON: EUA) but the level of trading in the shares was the highest it has been for many months. The share price recovered 176% to 3.8p.

Restaurants operator Tasty (LON: TAST) gained court approval of its restructuring plan on Tuesday afternoon. Tasty has got out of the leases of 23 sites. This leaves 38 restaurants, which are predominantly the Wildwood brand. This should improve EBITDA by up to £2.1m between 2023 and 2025. The share price rebounded 71.1% to 1.625p.

Mosman Oil & Gas (LON: MSMN) is paying $500,000 for a 10% interest in a US helium project in Las Animas County, Colorado. This is an area with known helium deposits. There are five helium prospects and a well will be drilled for each of them. The sale of oil and gas asset will help finance the move into helium. There were warrants exercised at 0.0125p. The share price rose 58.1% to 0.034p.

GRC International (LON: GRC) is recommending an 8p/share cash bid from Bloom Seed Bidco, which values the cybersecurity company at £8.6m. The bidder is a vehicle for technology investor Bloom, which can provide increased financial backing for the business. GRC joined AIM in 2018 at a time when there was investor interest in the cybersecurity sector. The flotation valuation was £40.2m at 70p/share. GRC has been loss making and never moved into profit. The share price increased 56.3% to 7.5p.

FALLERS

Beacon Energy (LON: BCE) has not been able to produce a stabilised flow rate from the SCHB-2 sidetrack in the Erfelden field in Germany. Based on bottom hole pressures and flow rates obtained the initial response from the reservoir was poor. The well will be temporarily shut-in and data analysed. This well was expected to produce 9,000 barrel of oil equivalent/day. This cash would have funded further exploration and development. The share price slumped 79.1% to 0.012p.

Clontarf Energy (LON: CLON) has failed to move through to the next stage of the bids for the seven priority salt pans in southern Bolivia because of its offtake partner’s poor credit rating. Management hopes that it can argue the case that the credit rating is not relevant. The share price dived 58.7% to 0.0155p.

Mohammmed Ashraf has been appointed chief executive of Kibo Energy (LON: KIBO) and James Parsons is joining the board to oversee a restructuring. The company will become a broader based energy company that includes oil and gas. There will be a review of existing interests. Stefania Barbaglio and Clive Roberts are also joining the board. The renewable energy company has raised £500,000 at 0.015p/share. The main assets are 83.2 million shares in MAST Energy Development (LON: MED) plus £849,000 owed by that company, 134.4 million shares in Katoro Gold (LON: KAT) and a portfolio of waste to energy projects. The receivable from MAST Energy Developments will be used to reduce the debt owed to RiverFort Global Opportunities from £767,000 to £400,000, which be structured as a two-year loan with a 10% annual interest rate. The Johannesburg Stock Exchange listing may be dropped. The share price fell 52.9% to 0.0165p.

Faron Pharmaceuticals (LON: FARN) has published a prospectus for a fundraising of up to €30.7m at €1/share (85p/share). This will include an open offer raising up to £6.8m and a REX retail offer that could raise up to £850,000. The retail offer closes on 19 June. The cash will provide sufficient funds for Finland-based Faron’s requirements in 2024, so it can reach a commercial partnership agreement to finance further product development. If the full amount is raised the cash should last until March 2025. Faron has committed to issue an additional 1.6 million shares to investors in the placing at €1.50/share in April, so that the effective price would be reduced to €1/share. The share price slipped 48.1% to 96p.

FTSE 100 sinks after blowout Non-Farm Payrolls

The FTSE 100 sank with global equities on Friday after US Non-Farm Payrolls provided a much stronger snapshot of the UK economy than investors had been expecting.

Non-farm payrolls rose by a whopping 272,000 jobs, much stronger than the expected 180,000. Such a strong beat in jobs added is great news for the US economy but terrible news for stocks.

The bumper Non-Farm Payrolls report effectively closes the door on a rate cut by the Federal Reserve next week and throws doubt over when the Federal Reserve will eventually cuts rates.

The big risk for the Federal Reserve is easing too quickly and leaving themselves vulnerable to a slowdown in the US economy. Easing borrowing costs when the economy is still humming will erode the impact of further rate cuts if and when the economy slows. This risk of cutting rates too early is the reason why financial markets are no longer pricing a 100% chance of a US interest rate cut in 2024.

Attention will shift to the US CPI reading due for release on Wednesday for further insight into the Fed’s next move. Should we see an inflation reading higher than expected, equities could come under real pressure.

“FOMC members continue, unsurprisingly, to place greater weight on the inflation side of the dual mandate, and are likely to reiterate next week that they are yet to obtain the ‘confidence’ being sought on a return towards the 2% target to enable the first rate cut to be delivered,” said Michael Brown, Senior Research Strategist at Pepperstone.

“As such, the May CPI report, also due next Wednesday, is likely to be a much more significant event, particularly after the core CPI metric fell, on an annual basis, to a near 3-year low in April.”

The prospect of few or no rate cuts in 2024 has sent equities into a tailspin and bond yields soaring. US futures were down heavily and the FTSE 100 fell in sympathy.

The FTSE 100 was trading negatively before the jobs data was released at 1.30pm and losses accelerated as the news hit the wires. The selloff was broad with 89 of the FTSE 100 constituents trading negatively at the time of writing.

Miners were the worst hit, with Fresnillo falling 4% and copper miner Antofagasta dropping 3.4%. JD Sports felt the pressure of higher borrowing costs for longer and fell 3%. Ocado never misses out on a big move and was down 2.5% after earlier this week it was confirmed they will be removed from the index in upcoming reshuffle.

Utilities companies were among the few companies trading in positive territory

Has SRT Marine Systems got recovery potential?

Maritime systems developer SRT Marine Systems (LON: SRT) admits that two coastguard contracts are unlikely to reach their project revenue milestones in the 15 months to Jun 2024. This means that there will be another loss. Despite the bad news, the share price recovered 4.4% to 19p.
The contracts have to go through final completion administrative processes and the timing is not controlled by AIM-quoted SRT Marine Systems. The largest contract is dependent on the completion of an inter-government loan. There should £45m of income recognised when this is finalised. Once the other contract is ver...

AIM movers: Kibo Mining restructuring and Safestay buys Brighton property

0

Angola-focused oil and gas company Corcel (LON: CRCL) has gained approvals to collect data for KON 11, KON 12 and KON 16 blocks in Angola. The survey will be done in the third quarter. There will be a financial update on 14 June. The share price rose 23.8% to 0.13p.

Norway-based First Seagull AS has acquired a 7.88% stake in Aferian (LON: AFRN). The share price is one-quarter higher at 4.5p.

Mathematical drug modelling company Physiomics (LON: PYC) has been awarded a contract by a UK biotech company. This will use the company’s virtual tumour technology. The project is valued at £162,000 and should be completed over five months. This will provide information for the reactivation of former oil and gas fields. The share price increased 7.69% to 1.4p.

Hostels operator Safestay (LON: SSTY) has acquired a property in Brighton from the University of East Sussex for £2.275m. This will be converted into a 220 bed premium hostel. It is 600 metres from the sea front and will cost £1m to convert. Shore Capital has been appointed nominated adviser and broker. Safestay reported full year revenues 18% higher at £22.5m. EBITDA rose 15% to £6.8m. NAV was 50p/share. The share price is 7.5% ahead at 21.5p.

FALLERS

Mohammmed Ashraf has been appointed chief executive of Kibo Energy (LON: KIBO) and James Parsons is joining the board to oversee a restructuring. The company will become a broader based energy company that includes oil and gas. There will be a review of existing interests. Stefania Barbaglio and Clive Roberts are also joining the board. The renewable energy company has raised £500,000 at 0.015p/share. The main assets are 83.2 million shares in MAST Energy Development (LON: MED) plus £849,000 owed by that company, 134.4 million shares in Katoro Gold (LON: KAT) and a portfolio of waste to energy projects. The receivable from MAST Energy Developments will be used to reduce the debt owed to RiverFort Global Opportunities from £767,000 to £400,000, which be structured as a two-year loan with a 10% annual interest rate. The Johannesburg Stock Exchange listing may be dropped. The share price slumped 46.7% to 0.016p.

Antimicrobial treatment developer Ondine Biomedical (LON: OBI) doubled 2023 revenues to $1.2m. Funding for the US phase 3 clinical trial for Steriwave is being explored and up to $22m is required to generate the data required. Ondine Biomedical raised $6.1m at 7p/share earlier this year. There are hospitals already using Steriwave to reduce the number of infections. The share price is 12.1% lower at 7.25p.

WIIT has decided not to make an offer for Redcentric (LON: RCN). The share price fell back 3.26% to 141p.